A patient with prolymphocytic leukemia achieved a prolonged survival of 44 months. Treatment with acute myelocytic leukemia agents induced remissions, but B-cell surface markers indicated the leukemia
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Observation:
Findings:
Implications: